AbbVie Hit with $150 Million Jury Verdict for Falsely Marketing Testosterone Product to Older Men

A federal jury in Illinois ordered pharmaceutical company AbbVie to pay 0 million in punitive damages to a plaintiff who alleged that his heart attack was the result of using its testosterone-boosting product, AndroGel. Although the jury found that AbbVie was not liable for the plaintiff’s injury, they ruled that the company had engaged in fraudulent and misleading advertising.

Learn more about this litigation at https://www.levinlaw.com/testosterone-lawsuit-heart-attacks-strokes-attorney-assistance